Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration

American Journal of Veterinary Research

Volumn 59, Issue 6, 1998, Pages 739-743

  Brink, Palle ^a,c   DeGraves, Fred ^a   Ravis, William R ^a   Johansen, Dorte ^b   Campbell, Jennifer D ^a   Duran, Sue H ^a  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Bjerke Equine Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DATA ANALYSIS; DRUG ACTIVITY; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PROTEIN BINDING; QUANTITATIVE DIAGNOSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; STEREOSPECIFICITY; SYNOVIAL FLUID LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; HORSES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; KETOPROFEN; LEAST-SQUARES ANALYSIS; METABOLIC CLEARANCE RATE; PROTEIN BINDING; STEREOISOMERISM; SYNOVIAL FLUID;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0031842394     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gregoricka MJ, Busch KR, Pollet RA. Clinical evaluation of ketoprofen: a new nonsteroidal anti-inflammatory drug for use in horses, in Proceedings. 37th Annu Conv Am Assoc Equine Pract 1991;19-26.
2. Gregoricka MJ, Sutherland SF, Dedrickson BJ, et al. Assessment of the intramuscular administration of ketoprofen. Equine Pract 1990;12:15-22.
3. Foreman JH, Grubb TL, Inoue OJ. Single-dose intravenous flunixin meglumine versus ketoprofen in experimentally induced lameness in the horse, in Proceedings. 40th Annu Conv Am Assoc Equine Pract 1991;51.
4. Longo F, Autefage A, Bayle R, et al. Efficacite du ketoprofene dans les affections musculo-squelettiques du cheval. Bull Soc Vét Prat de France 1990;74:349-367.
5. Longo F, Autefage A, Bayle R, et al. Efficacite du ketoprofene dans le traitement des coliques chez le cheval. Bull Soc Vét Prat de France 1990;74:377-394.
6. Betley M, Sutherland SF, Gregoricka MJ, et al. The analgesic effect of ketoprofen for use in treating equine colic as compared to flunixin meglumine. Equine Pract 1991;13:11-16.
7. Longo F, Autefage A, Bayle R, et al. Efficacy of a non-steroidal anti-inflammatory, ketofen 10% (ketoprofen), in the treatment of colic in horses. Equine Vet Sci 1992;12:311-315.
8. Owens JG, Kamerling SG, Stanton SR, et al. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Vet J 1995;27:296-300.
9. Jaussaud P, Bellon C, Besse D, et al. Enantioselective pharmacokinetics of ketoprofen in horses. J Vet Pharmacol Ther 1993; 16:373-376.
10. Landoni MF, Lees P. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling. Equine Vet J 1995;27:247-256.
11. Sams R, Gerken DF, Ashcraft SM. Pharmacokinetics of ketoprofen after multiple intravenous doses to mares. J Vet Pharmacol Ther 1995;18:108-116.
12. Owens JG, Kamerling SG, Barker SA. Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis. J Vet Pharmacol Ther 1995;18:187-195.
13. Sünderhauf E. Stereoselektive untersuchungen zur analgetischen wirksamkeit von ketoprofen. Munchen: Tierarztliche Fakultat, Ludwig-Maximilians Universitat, 1992;1-62.
14. Dubois-Presle N, Lapicque F, Maurice M-H, et al. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide. Mol Pharmacol 1995;47:647-653.
15. Mehvar R, Jamali F, Pasutto F. Liquid chromatographic assay of ibuprofen enantiomers in plasma. Clin Chem 1988;34:493-496.
16. Shargel L, Yu ABC. Applied biopharmaceutics and pharmacokinetics. 2nd ed. City, Conn: Appleton-Century-Crofts, 1985;52-62,107-112.
17. Riviere JE. Veterinary clinical pharmacokinetics. II. Modeling. Compend Contin Educ Pract Vet 1988;10:314-328.
18. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc, 1982;409-417.
19. Wong C-Y, Wang D-P. Pharmacokinetics of ketoprofen after intravenous and intramuscular administrations to rabbits. Drug Develop Industr Pharm 1994;20:1075-1083.
20. Oukessou M, Zine-Filali R, Van Gool F, et al. Ketoprofen pharmacokinetics in camel (camelus dromedarius). Indian Vet J 1995; 72:233-236.
21. Netter P, Bannwarth B, Lapicque F, et al. Total and free ketoprofen in serum and synovial fluid after intramuscular injection. Clin Pharmacol Ther 1987;42:555-561.
22. Shpigel NY, Chen R, Winkler M, et al. Anti-inflammatory ketoprofen in the treatment of field cases of bovine mastitis. Res Vet Sci 1994;56:62-68.
23. Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1983;8:297-331.
24. Grennan DM, Aarons L, Salisbury R. Problems with demonstrating NSAID concentration-response relationships. Agents Actions Suppl 1985;17:163-168.
25. Day RO, Graham GG, Williams KM, et al. Clinical pharmacology of non-steroidal anti-inflammatory drugs. J Pharmacol Ther 1987;33:383-433.
26. Lehmann VW, Wintzer H-J, Frey H-H. Kinetik einiger analgetisch-antiinflammatorischer arzneimittel in serum und synovia beim pferd. DTW Dtsch Tierärztl Wochenschr 1981;88:218-220.
27. McCrea JD, Telford A-M, Kaye CM, et al. A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis. Curr Med Res Opin 1986;10:73-81.
28. Netter P, Bannwarth B, Royer-Morrot M-J. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1989;117:145-162.
29. Foster RT, Jamali F, Russell AS. Ketoprofen enantiomers in synovial fluid. J Pharm Sci 1989;78:881-882.
30. Wallis WJ, Simkin PA. Antirheumatic drug concentrations in human synovial fluid and synovial tissue: observations on extravascular pharmacokinetics. Clin Pharmacokinet 1983;8:496-522.
31. Jamali F, Russell AS, Foster RT, et al. Ketoprofen pharmacokinetics in humans: evidence of enantiomeric inversion and lack of interaction. J Pharm Sci 1990;79:460-461.
32. Foster RT, Jamali F. Stereoselective pharmacokinetics of ketoprofen in the rat: influence of route of administration. Drug Metab Dispos 1988;16:623-626.
33. Jamali F. Pharmacokinetics of enantiomers of chiral-steroidal anti-inflammatory drugs. Eur J Drug Metab Pharmacokinet 1988; 13:1-9.
34. Abas A, Meffin PJ. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition. J Pharmacol Exp Ther 1987;240:637-641.
35. Iwakawa S, He X, Hashimoto S, et al. Stereoselective disposition of ketoprofen in rats. Drug Metab Dispos 1991;19:717-719.
36. Brune K, Geisslinger G, Menzel-Soglowek S. Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. J Clin Pharmacol 1992;32:944-952.
37. Hutt AJ, Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids: a novel route with pharmacological consequences. J Pharm Pharmacol 1983;35:693-704.
38. Soraci A, Benoit E, Jaussaud P, et al. Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses. Am J Vet Res 1995;56:358-361.
39. Lees P, Delatour P, Benoit E, et al. Pharmacokinetics of carprofen enantiomers in the horse. Acta Vet Scand 1991;27(Suppl): 249-251.
40. Benoit E, Soraci A, Delateur P. Chiral inversion as a parameter for interspecies and intercompound discrepancies in enantiospecific pharmacokinetics, in Proceedings. 6th Congr Eur Assoc Vet Pharmacol Ther 1994.
41. Nakamura Y, Yamaguchi T, Takahashi S, et al. Optical isomerization mechanism of R(-)-hydrotropic acid derivates. J Pharmacobiodyn 1981;4:S-1.
42. Plumb DC. Veterinary drug handbook. 2nd ed. Ames, Iowa: Iowa State University Press, 1995;353-354.
43. Hayball PJ, Nation RL, Bochner F, et al. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol 1988;26:765-770.
44. Riviere JE. Veterinary clinical pharmacokinetics. I. Fundamental concepts. Compend Contin Educ Pract Vet 1988;10:24-30.
45. 2. Relation avec les concentrations plasmatiques et synoviales. Revue Rhumatisme 1988;55: 205.
46. Gaucher A, Netter P, Faure G, et al. Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid. Eur J Pharmacol 1983;25:107-112.
47. Furst DE. Synovial fluid kinetics of non-steroidal anti-inflammatory drugs. Agent Actions 1985;17:65-78.
48. Famaey JP. Synovial anti-inflammatory and antirheumatic drug levels: importance in therapeutic efficacy. In: Lewis AJ, Furst DE, eds. Nonsteroidal anti-inflammatory drugs. Mechanisms and clinical use. New York: Marcel Dekker, 1987;189-199.
49. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker Inc, 1975;56.
50. Conner GH, Riley WF, Beck CC, et al. Arquel (CI-583), a new non-steroidal, anti-inflammatory drug for horses, in Proceedings. 22th Annu Conv Am Assoc Equine Pract 1973;81-90.
51. McEvoy GK. American hospital formulary service. Drug information. Bethesda, Md: American Society of Hospital Pharmacists Inc, 1991;1107-1112.
52. Lewellen OR, Templeton R. The pharmacokinetics of ketoprofen in man during and after repeated oral dosing (50-mg q.i.d.) with Orudis. Scand J Rheumatol 1976;10(Suppl):53-62.